Fiera Capital Corp Gilead Sciences, Inc. Transaction History

Fiera Capital Corp

$31.6 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$62.32 - $89.47 $1.79 Million - $2.57 Million	-28,775 Reduced 79.41%	7,460 $640,000
Q3 2022 Nov 03, 2022	BUY	$59.54 - $68.01 $148,850 - $170,025	2,500 Added 7.41%	36,235 $2.24 Million
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $1.14 Million - $1.28 Million	19,675 Added 139.94%	33,735 $2.09 Million
Q1 2022 May 09, 2022	SELL	$57.92 - $72.58 $995,065 - $1.25 Million	-17,180 Reduced 54.99%	14,060 $836,000
Q4 2021 Feb 08, 2022	SELL	$64.88 - $73.64 $652,368 - $740,450	-10,055 Reduced 24.35%	31,240 $2.27 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $286,328 - $308,916	4,230 Added 11.41%	41,295 $2.88 Million
Q2 2021 Aug 11, 2021	BUY	$63.47 - $69.35 $668,973 - $730,948	10,540 Added 39.74%	37,065 $2.85 Million
Q1 2021 May 11, 2021	SELL	$60.0 - $68.46 $58,500 - $66,748	-975 Reduced 3.55%	26,525 $1.71 Million
Q4 2020 Feb 09, 2021	BUY	$56.65 - $64.55 $1.56 Million - $1.78 Million	27,500 New	27,500 $1.6 Million
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $208,097 - $261,646	-3,351 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$72.34 - $84.0 $2.54 Million - $2.95 Million	-35,148 Reduced 91.3%	3,351 $258,000
Q1 2020 May 08, 2020	BUY	$62.63 - $80.22 $2.41 Million - $3.09 Million	38,499 New	38,499 $2.88 Million
Q1 2019 May 10, 2019	SELL	$62.53 - $70.05 $575,276 - $644,460	-9,200 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $982,806 - $1.28 Million	-16,234 Reduced 63.83%	9,200 $575,000
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $17,107 - $18,940	240 Added 0.95%	25,434 $1.96 Million
Q2 2018 Aug 02, 2018	SELL	$64.88 - $75.68 $34,256 - $39,959	-528 Reduced 2.05%	25,194 $1.79 Million
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $89,010 - $108,513	-1,222 Reduced 4.54%	25,722 $1.94 Million
Q4 2017 Feb 09, 2018	SELL	$71.15 - $83.52 $282,394 - $331,490	-3,969 Reduced 12.84%	26,944 $1.93 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $2.23 Million - $2.64 Million	30,913	30,913 $2.51 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.

Account